Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-02-08
2005-02-08
Fonda, Kathleen K. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S053000
Reexamination Certificate
active
06852708
ABSTRACT:
For the prevention of the narrowing of the tubular walls of an animal after the tubular walls have been traumatized, the administration of a therapeutically effective non-toxic amount of a form of Hyaluronic Acid selected from Hyaluronic Acid, salts thereof and combinations thereof to the animal to prevent narrowing of the tubular walls.
REFERENCES:
patent: 4141973 (1979-02-01), Balazs
patent: 4272522 (1981-06-01), Balazs
patent: 4820732 (1989-04-01), Shell et al.
patent: 4929602 (1990-05-01), Harker et al.
patent: 5087244 (1992-02-01), Wolinsky et al.
patent: 5092841 (1992-03-01), Spears
patent: 5116864 (1992-05-01), March et al.
patent: 5614506 (1997-03-01), Falk et al.
patent: 5767106 (1998-06-01), Turley et al.
patent: 1205031 (1986-05-01), None
patent: 2042159 (1991-12-01), None
patent: 0 197 718 (1986-10-01), None
patent: 356275 (1990-02-01), None
patent: WO 9104058 (1991-04-01), None
patent: WO 9118639 (1991-12-01), None
patent: WO 9205782 (1992-04-01), None
patent: WO 9207852 (1992-05-01), None
patent: WO 9208472 (1992-05-01), None
patent: WO 9209561 (1992-06-01), None
Ausprunk, D.H., Boudreau, C.L. and Nelson, D.A., “Proteoglycans in the microvasculature II: Histochemical localization in proliferating capillaries of the rabbit cornea”,Am. J. Pathol. 1981, 103:367-375.
Baumgartner, H.R., 1963, Z.Ges. Exp. Med., 137:227.
Berk., B.C. et al in theJ. Am. Coll. Cardiol. dated 1991 vol. 17 #6 Supplement B, pp. 111B-117B.
Boudreau, N. and Rabinovitch, M., “Developmentally regulated changes in extracellular matrix in endothelial and smooth Muscle Cells in the ductus arteriosus may be related to intimal proliferation”,Lab. Invest. 1991, 64(2):187-199.
Boudreau, N., Turley, E.A. and Rabinovitch, M., Fibronectin, “Hyaluronan, and a Hyaluronan Binding Protein contribute to increased ductus arteriosus smooth muscle cell migration”,Develop. Biol. 1991, 143:235-247.
Braun DP, Taylor SG, Harris JB, Modulation of immunity in cancer patients by prostaglandin antagonists., In:Immunity to Cancer. Alan R. Liss, Inc., 1980: 449-456.
Bray, B.A., Sampson, P.M., Osman, M., Giandomenico, A., and Turino, G.M., “Early changes in lung tissue hyaluronan (hyaluronic acid) and hyaluronidas in bleomycin-induced alveolitis in hamsters”,Am. Rev. Resp. Dis.1991, 143:284-288.
Casscells, W., “Migration of smooth muscle and endothelial cells: Critical events in restenosis”,Circulation1992, 86(3):723-729.
Clowes, A.W., Clowes, M.M., Au, Y.P.T., Reidy, M.A. and Berlin, D., “Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery”,Circ. Res. 1990, 67:61-67.
Clowes, A.W., Reidy, M.A. and Clowes, M.S., “Mechanisms of stenosis after arterial injury”,Lab. Invest., 1983, 49(2):208-215.
Clowes, A.W. and Schwartz, S.M., “Significance of quiescent smooth muscle cell migration in the injured rat carotid artery”,Circ. Res. 1985, 56:139-?.
Dustin, M.L. and Springer, T.A.,Annu. Rev. Immunol. 1991, 9:27-66.
Ferns, G.A.A., Forster, L.A., Stewart-Lee, A., Konneh, M., Nourooz-Zadeh, J., Anggard, E.E., (1992) “PROBUCOL inhibits neo-internal thickening and macrophage accumulation after balloon injury in the cholesterol-fed rabbit”,PROC. Natl. ACAD, Sci., USA89:11312-11316.
Ferns, G.A.A., Reidy, M.A., Ross, R. 1990 “Vascular effects of cyclosporin A in vitro and in vivo”,AM. J. Path. 1990, 137, 403-413.
Ferns, G.A.A., Stewart-Lee, A.A. and Anggård, E.E., “Arterial response to mechanical injury: balloon catheter de-endothelialization”,Atherosclerosis1992, 92:89-104.
Glazier, J.J., Williams, M.G., Madden, S. and Rickards, A.F., “Clinical outcome following coronary balloon angioplasty in 100 consecutive patients with multivessel coronary artery disease”,J Royal College Phys LondonOct. 1990; 24(4):292-294.
Goodwin, J.S., “Prostaglandin E and Cancer Growth Potential for Immunotherapy with Prostaglandin Synthesis Inhibitors”,Augmentive Agents in Cancer Therapy, Raven Press, New York, 1981: 393-415.
Hardwick, C., Hoare, K., Owens, R., Hohn, H.P., Hook, M., Moore, D., Cripps, V. Austen, L., Nance, D.M. and Turley, E.A., “Molecular cloning of a novel Hyaluronan receptor that mediates tumor cell motility”,J. Cell. Biol. 1992, 117(6):1343-1350.
Haynes, B.F., Liao, H-X and Patton, K.L., “The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms”,Cancer Cells1991, 3(9):347-350.
Jawien, A., Bowen-Pope, D.F., Lindner, V., Schwartz, S.M. and Clowes, A.W., “Platelet-derived Growth Factor promotes smooth muscle cell migration and intimal thickening in a rat model of balloon angioplasty”,J. Clin. Invest. 1992, 89:507-511.
Kockx, M.M., De Meyer, G.R.Y., Jacob, W.A., Bult, H. and Herman, A.G., “Triphasic sequence of neointimal formation in the cuffed artery of the rabbit”,Arterioscl. Thromb., 1992, 12:1447-1457.
Lasky, L.A., “Selections: Interpreters of cell-specific carbohydrate information during inflammation”,Science, 1992, 258:964-969.
Laurent, T.C. and Fraser, J.R.E., “Hyaluronan”,Faseb J., 1992, 6:2397-2404.
Lövqvist, A., Emanuelsson, H., Nilsson, J., Lundqvist, H. and Carlsson, J., “Pathophysiological mechanisms for restenosis following coronary angioplasty: possible preventative alternatives”,J., Int. Med., 1993, 233:215-226.
Majack, R.A. and Clowes, A.W., “Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans”,J. Cell. Physiol. 1984, 118:253-256.
Majesky, M.W., Linder, V., Twardzik, D.R., Schwartz, S.M. and Reidy, M.A., “Production of Transforming Growth Factor β1during repair of arterial injury”,J. Clin. Invest. 1991, 88:904-910.
Merwin, J.R., Roberts, A., Kondaiah, P., Tucker, A. and Madri, J.A., “Vascular cell responses to TGF-β3mimic those TGF-β1in vitro”, Growth Factors1991, 5(149-158).
Miano, J.M., Vlasic, N., Tota, R.R. and Stemerman, M.B., “Smooth muscle cell Immediate-early gene and growth factor activation follows vascular injury: A putative in vivo mechanism for autocrine growth”,Arterioscler Thromb, 1993, 13:211-219.
Rakugi, H., Jacob, H.J., Krieger, J.E., Ingelfinger, J.R. and Pratt, R.E., “Vascular injury induces aniotensinogen gene expression in the media and neointima”,Circulation, 1993, 87:283-290.
Ripellino, J.A., Killinger, M.M., Margolis, R.U. and Margolis, R.K., “The hyaluronic acid binding region as a specific probe for the localization of hyaluronic acid in tissue sections”,J. Hisotchem. Cytochem.1985, 33:1066-1086.
Ross, R., “The pathogenesis of atherosclerosis: a perspective for the 1990's”,Nature1993, 362:801-809.
Samuel, S.K., Hurta, RAR, Spearman, M.A., Wright, J.A., Turley, E.A. and Greenberg, A.H., “TGF-β1stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan”,J. Cell Biol.1993, 123(3), 749-58.
Shi, Y., Kornovski, B.S., Savani, R.C. and Turley, E.A., “A rapid, multiwell colormetric assay for chemotaxis”,J. Immunol. Methods1993, 164(2), 149-54.
Stevenson, M.M., Kongshovn, A.L. and Skamen, E., “Genetic linkage of resistance to Listeria monocytogenes with macrophage inflammatory response”,J. Immunol. 1981, 127:402.
Tanaka, Y., Adams, D.H. and Shaw, S., “Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes”,Immunol Today1993, 14(3):111-115.
Toole, B.P., “Developmental role of hyaluronate”,Conn. Tiss. Res. 1982, 10:93-100.
Toole, B.P., “Hyaluronan and its binding proteins, the hyaladherins”,Curr. Opn. Cell. Biol. 1990, 2:839-844.
Turley, E.A., Austin, L., Vandeligt, K. and Clary, C., “Hyaluronan and a cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cells”, 1991,J. Cell Biol.,
Ascuali Samuel Simon
Falk Rudolf Edgar
Turley Eva Anne
Edwards & Angell LLP
Fonda Kathleen K.
Jagotec AG
LandOfFree
Use of hyaluronic acid and forms to prevent the narrowing of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of hyaluronic acid and forms to prevent the narrowing of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of hyaluronic acid and forms to prevent the narrowing of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3463013